Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAib Group Regulatory News (AIBG)

Share Price Information for Aib Group (AIBG)

Share Price is delayed by 15 minutes
Get Live Data
872.00    -20.00 (-2.24%)
Bid:
870.00
Ask:
884.00
Spread: 14.00 (1.609%)
Market Cap: £18.51b
AIBG Live PriceLast checked at - London Stock Exchange

Intraday Aib Group Share Chart

AIB Group plc - Medium-Term Targets

2 Dec 2022 07:00

RNS Number : 3564I
AIB Group PLC
02 December 2022
Β 

Β 

EMBARGO 07:00

2 December 2022

Β 

Β 

AIB GROUP PLC - MEDIUM-TERM TARGETS

AIB to deliver a ROTE of greater than 13% in 2024

Β 

AIB Group plc today announces revised medium-term targets as follows:

Β 

Revised medium-term targets:

Β· Absolute cost(1) target of

Β· CET1(2) target >13.5%

Β· RoTE(3) >13% in 2024

Β 

With significant momentum in income we also expect to deliver a cost income ratio of c. 50% by 2024.

Β 

Additionally today we outline our plans for shareholder distributions. Subject to a supportive macroeconomic environment and annual Board and required regulatory approvals, in the coming years we will seek to move towards our CET1 target by prudently increasing levels of distribution, supplementing dividend with share buybacks where appropriate.

Β 

Colin Hunt, Chief Executive Officer commented:Β 

"We set out our strategy in December 2020 to fulfil our ambition of being at the heart of our customers' financial lives. Since then we have made significant progress in growing and strengthening the Group through an enhanced product suite, a transforming operating model and an increased customer base - now heading to over three million customers.

Β 

While global economic headwinds exist, the Irish economy continues to deliver economic growth and demonstrate resilience. Against this domestic backdrop and given the changing banking landscape and evolving operating environment, we have revised our medium-term targets and now expect a RoTE of greater than 13% in 2024. We continue to implement our strategy to enhance shareholder value and deliver sustainable returns."

Β 

Analyst conference call

A conference call for analysts, hosted by Colin Hunt, CEO, and Donal Galvin, CFO will be held from 10:00 - 11:00 GMT. Please click on the link below and enter your details to receive a unique PIN to access the call or to request a free call back which connects you to the meeting automatically up to 15 minutes before the event.

Β 

https://register.vevent.com/register/BI6225f5655d4043e1a9524dcdffb81c96

Β 

Please note it is advisable to register in advance

Β 

Further details available on our website https://aib.ie/investorrelations/aib-investor-updates

Β 

Β 

Footnotes:

1) Costs before bank levies and regulatory fees and exceptional items

2) CET1 fully loaded

3) RoTE = (PAT - AT1) / (CET1 @ 13.5% of RWAs; RoTE: return on tangible equity

Β 

-ENDS-

Β 

For further information, please contact:

Niamh Hore / Siobhain Walsh

Paddy McDonnell / Graham Union

Investor Relations

Media Relations

AIB Group

AIB Group

Dublin

Dublin

Tel: +353-86-3135647 / +353-87- 3956864

Tel: +353-87-7390743 / +353-85 2088343

email: niamh.a.hore@aib.ie

siobhain.m.walsh@aib.ie

email: paddy.x.mcdonnell@aib.ie

Β 

Β 

Β 

Forward Looking StatementsΒ 

This document contains certain forward looking statements with respect to the financial condition, results of operations and business of AIB Group and certain of the plans and objectives of the Group. These forward looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward looking statements sometimes use words such as 'aim', 'anticipate', 'target', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', 'may', 'could', 'will', 'seek', 'continue', 'should', 'assume', or other words of similar meaning. Examples of forward looking statements include, among others, statements regarding the Group's future financial position, capital structure, Government shareholding in the Group, income growth, loan losses, business strategy, projected costs, capital ratios, estimates of capital expenditures, and plans and objectives for future operations. Because such statements are inherently subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward looking information. By their nature, forward looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by these forward looking statements. These are set out in Principal risks on pages 28 to 30 of the Annual Financial Report 2021 and updated on page 37 of the Half-Yearly Financial Report 2022. In addition to matters relating to the Group's business, future performance will be impacted by the direct and indirect impacts of the COVID-19 pandemic, the direct and indirect consequences of the Russia-Ukraine War on European and global macroeconomic conditions, the impact of higher inflation on customer sentiment and by Irish, UK and wider European and global economic and financial market considerations. Any forward looking statements made by or on behalf of the Group speak only as of the date they are made. The Group cautions that the list of important factors on pages 28 to 30 of the Annual Financial Report 2021 is not exhaustive. Investors and others should carefully consider the foregoing factors and other uncertainties and events when making an investment decision based on any forward looking statement.

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCEAAAFEAXAFAA
Date   Source Headline
29th Mar 20229:48 amRNSStabilisation Notice
28th Mar 202210:43 amRNSStabilisation Notice
28th Mar 20229:13 amRNSStabilisation Notice
4th Mar 20222:00 pmRNSNotification of Transaction by PDMR
3rd Mar 20227:00 amRNSAnnual Financial Report
25th Feb 20223:03 pmRNSNotification of Major Holdings
25th Feb 20227:00 amRNSDirectorate Change
26th Jan 20227:06 amRNSAIB Group plc - SREP
20th Jan 20229:00 amRNSNotification of Major Holdings
21st Dec 20217:13 amRNSAIB - State's intention to sell part shareholding
21st Dec 20217:00 amRNSIntention to sell shares in AIB Group Plc
25th Nov 20219:00 amRNSChange in Director Details
23rd Nov 20217:00 amRNSAIB announces sale of SME portfolio in GB
3rd Nov 20217:00 amRNSAIB Group plc - Q3 2021 Trading Update
28th Oct 20219:30 amRNSAppointment of Chair
14th Oct 20215:11 pmRNSAIB - sale of non-performing loan portfolio
5th Oct 202110:00 amRNSAIB confirms date for Q3 2021 Trading Update
14th Sep 202111:00 amRNSAppointment of Directors
1st Sep 20217:00 amRNSAIB - acquisition of Goodbody completion
6th Aug 202112:30 pmRNSNotification of Transaction by PDMR and PCA
4th Aug 20217:00 amRNSAIB - Half-Yearly Financial Results 2021
30th Jul 20215:28 pmRNSAIB Group plc – EBA European-Wide Stress Test 2021
30th Jun 20213:00 pmRNSAIB Group confirms date for HY21 Financial Results
28th Jun 20217:02 amRNSAIB acquisition of EUR4.2bn Ulster Bank loans
25th Jun 202111:00 amRNSNotification of Major Holdings
23rd Jun 20215:36 pmRNSAIB forms JV with Great-West Lifeco
18th Jun 202110:00 amRNSAppointment of Director
28th May 202111:00 amRNSAppointment of Executive Director
11th May 202112:00 pmRNSStabilisation Notice
10th May 20218:26 amRNSStabilisation Notice
6th May 20213:30 pmRNSResults of AGM 2021
6th May 20217:00 amRNSAIB Group plc Q1 2021 Trading Update
20th Apr 20211:04 pmRNSAIB confirms date for Q1 2021 Trading Update
1st Apr 20213:00 pmRNSNotice of Annual General Meeting 2021
29th Mar 202112:00 pmRNSChange in Director Details
16th Mar 20214:45 pmRNSChange in Director Details
15th Mar 20213:00 pmRNSAppointment of Director
11th Mar 202111:00 amRNSUpdate on Migration from CREST to Euroclear Bank
10th Mar 20219:30 amRNSNotification of Transaction by PDMR
8th Mar 202110:20 amRNSNotification of Transaction by PDMR
5th Mar 20217:00 amRNSAIB Group plc - 2020 Annual Financial Results
2nd Mar 20212:00 pmRNSAIB Group plc - Acquisition of Goodbody
19th Feb 20217:12 amRNSAIB – Sale of non-performing loan portfolio
19th Feb 20217:10 amRNSAIB-potential acq Ulster Bk's Corp & Comm loan bk
5th Feb 202112:00 pmRNSResults of Extraordinary General Meeting
22nd Jan 202110:00 amRNSAppointment of Director
14th Jan 202110:00 amRNSNotice of Results - AIB to publish on 5 March 2021
11th Jan 20213:00 pmRNSNotice of Extraordinary General Meeting
30th Dec 20207:00 amRNSAIB Group plc - Currency Change on LSE
22nd Dec 202012:30 pmRNSForm 8.3 - Studio Retail Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.